Literature DB >> 2364107

Growth-dependent modulation of type I collagen production and mRNA levels in cultured human skin fibroblasts.

J K Mäkelä1, T Vuorio, E Vuorio.   

Abstract

Five human skin fibroblast lines were studied for type I collagen production and type I procollagen mRNA levels through the different growth phases. The cells were plated at low density and followed for 11 days at daily intervals through the stages of rapid growth and visual confluency until the cultures reached stationary growth phase. Each day one culture flask was labeled with [3H]proline for 24 h, and analyzed for production of radiolabeled type I collagen into culture medium. The cell layers were counted and subjected to isolation of cytoplasmic RNA and determination of type I procollagen mRNA levels. The results revealed an approx. 2-fold increase in procollagen production and mRNA levels when the cells reached visual confluency. Thereafter the synthesis rates and mRNA levels remained relatively constant, although a decreasing tendency of both parameters was observed upon further culturing. The results confirm that determination of cell density is important when cell cultures are used for measurement of collagen synthesis or mRNA levels. For determination of pro alpha 2(I) collagen mRNA an 1193 bp cDNA clone was constructed using RNA extracted from human fetal calvaria. Sequencing of the clone revealed some nucleotide and amino acid differences between the previously published sequences. This suggests the presence of more individual variation in procollagen coding sequences than expected.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2364107     DOI: 10.1016/0167-4781(90)90037-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Collagen biosynthesis and type I and type III procollagen mRNA in lichen sclerosus et atrophicus.

Authors:  R Panizzon; T Vuorio; L Bruckner-Tuderman
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  The protein phosphatase inhibitor okadaic acid suppresses type I collagen gene expression in cultured fibroblasts at the transcriptional level.

Authors:  J Westermarck; E Ilvonen; V M Kähäri
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

3.  Insulin-like growth factor I-dependent regulation of prolidase activity in cultured human skin fibroblasts.

Authors:  W Miltyk; E Karna; S Wołczyński; J Pałka
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

4.  Butyrate-induced collagen biosynthesis in cultured fibroblasts is independent on alpha2beta1 integrin signalling and undergoes through IGF-I receptor cascade.

Authors:  Ewa Karna; Wojciech Miltyk; Jerzy A Pałka
Journal:  Mol Cell Biochem       Date:  2006-03-16       Impact factor: 3.396

5.  Phosphoenolpyruvate-dependent inhibition of collagen biosynthesis, alpha2beta1 integrin and IGF-I receptor signaling in cultured fibroblasts.

Authors:  Ewa Karna; Jerzy A Palka
Journal:  Mol Cell Biochem       Date:  2008-05-21       Impact factor: 3.396

6.  Integrin alpha2beta1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the alpha2 cytoplasmic tail.

Authors:  J Ivaska; H Reunanen; J Westermarck; L Koivisto; V M Kähäri; J Heino
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

7.  The mechanism of oxythiamine-induced collagen biosynthesis in cultured fibroblasts.

Authors:  Lukasz Szoka; Ewa Karna; Jerzy Palka
Journal:  Mol Cell Biochem       Date:  2015-01-28       Impact factor: 3.396

8.  Enalapril stimulates collagen biosynthesis through prolidase-dependent mechanism in cultured fibroblasts.

Authors:  Lukasz Szoka; Ewa Karna; Renata Pawlak Morka; Jerzy A Palka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-03-17       Impact factor: 3.000

9.  The mechanism of hydralazine-induced collagen biosynthesis in cultured fibroblasts.

Authors:  Ewa Karna; Lukasz Szoka; Jerzy A Palka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-24       Impact factor: 3.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.